Export to China jumps by 17pc in fiscal year '17.

[gslv mk3]

1. Pharma market is saturated in India. Active pharmaceutical ingredient (API) and bulk active ingredients are much cheaper in India and some Indian companies routinely undercut dosage of API's for local and exported drugs, and pricing in India is much cheaper due to some of this dhokeybaaji. Part of the Indian market is used to substandard drugs especially in BIMARU states. It's a mess.

2. Bangladesh gets preferential treatment for drug exports (even patented ones) to all types of markets, but primarily undeveloped and underutilized ones. Indian Pharma majors like Sun Pharma and others have set up local manufacturing subsidiaries here to export drugs as well. We are too busy exporting to profitable markets and don't care about the market-protection tomfoolery and racket in India.

Lot of hot air coming from a nation that exports just $ 80 million worth pharmaceuticals @Nilgiri

http://bdnews24.com/business/2016/01/24/pharmaceutical-exports-from-bangladesh-rise-sharply.

 

[Species]

Lot of hot air coming from a nation that exports just $ 80 million worth pharmaceuticals @Nilgiri

http://bdnews24.com/business/2016/01/24/pharmaceutical-exports-from-bangladesh-rise-sharply.

It's not about quantity but quality with reasonable price,

http://bdnews24.com/health/2015/03/09/bangladesh-makes-hepatitis-wonder-drug
Bangladesh makes hepatitis wonder drug

 

[gslv mk3]

It's not about quantity but quality with reasonable price,

Sure, we exported $16 billion worth pharma without any quality.

Don't claim that 'we are too busy exporting to profitable markets' when your pharma exports haven't crossed $100 million.

 

[Species]

Sure, we exported $16 billion worth pharma without any quality.

Don't claim that 'we are too busy exporting to profitable markets' when your pharma exports haven't crossed $100 million.

There is a reason. So far our pharma companies were mainly concerned about the domestic market (which is worth $3 billion at present) where they hold a market share of about 97%. Now they are gearing up for bulk exports by establishing new plants to produce drugs dedicated to foreign markets. In fact, they have just begun to get receive FDA approval and to commence export to the US.

 

[gslv mk3]

There is a reason. So far our pharma companies were mainly concerned about the domestic market (which is worth $3 billion at present)

link please....

 

[Species]

link please....

Spend some more data and use Google. You can send me your internet bill, no problem.

 

[UKBengali]

link please....

Dude it is true with a 250 billion dollar economy and 160 million population.
It is not worth spending 5 minutes googling something that looks right.

 

[gslv mk3]

Dude it is true with a 250 billion dollar economy and 160 million population.

Spend some more data and use Google. You can send me your internet bill, no problem.

Says 1.4 billion in 2014

http://www.thedailystar.net/supplem...window-opportunity-the-pharma-industry-210937

Says 1.96 billion in 2016

http://www.thedailystar.net/supplem...window-opportunity-the-pharma-industry-210937

Where does $3 billion come from ?

 

[Species]

Says 1.4 billion in 2014

http://www.thedailystar.net/supplem...window-opportunity-the-pharma-industry-210937

Says 1.96 billion in 2016

http://www.thedailystar.net/supplem...window-opportunity-the-pharma-industry-210937

Where does $3 billion come from ?

$1.96 billion in 2015. Should be around $3 billion in 2017 with 20% annual growth. Add to that the informal drug market which must be as large as the formal.

 

[gslv mk3]

$1.96 billion in 2015. Should be around $3 billion in 2017 with 20% annual growth.

My bad, messed up the links. ~$2 billion is for 2016- link here

According to the IMS data of second quarter of 2016, the current domestic pharma market stands at BDT 15,640 crore with about 280 companies operating.

 

[Species]

My bad, messed up the links. ~$2 billion is for 2016- link here

According to the IMS data of second quarter of 2016, the current domestic pharma market stands at BDT 15,640 crore with about 280 companies operating.

Hmmm, now add the informal market.

 

[gslv mk3]

Hmmm, now add the informal market.

You mean the other drugs ? :

 

[Species]

You mean the other drugs ? :/

Informal means selling without any registration or approval from the government.

 

[UKBengali]

You mean the other drugs ? :

 

[Nilgiri]

Lot of hot air coming from a nation that exports just $ 80 million worth pharmaceuticals @Nilgiri

http://bdnews24.com/business/2016/01/24/pharmaceutical-exports-from-bangladesh-rise-sharply.

Its still a better ratio than the time and brouhaha they invest into their defense rumor mill here

Bilal and the rest are just going to have a nasty realisation when they see just how BD pharma exports flatline quick and hard at a terribly low base to begin with.....but it will be just like the Walton thing at that point too I guess (i.e move on to the next bunch of fake industry projections with absent data).

Then they get mad at people outside subcontinent realising it too like @madokafc